TechNavio's analysts forecast the Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018. One of the key factors contributing to this market growth is the shorter development timelines. The Global Orphan Drugs market has also been witnessing the growing awareness of orphan drugs. However, the high cost of drug development could pose a challenge to the growth of this market. TechNavio's report, the Global Orphan Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Orphan Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space are Novartis AG, F. Hoffmann-La Roche Ltd., Celgene Corp., Pfizer Inc., and Sanofi S.A. Other vendors mentioned in the report are Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals Inc., Amgen Inc., Baxter International Inc., Biogen Idec Inc., Bristol-Myers-Squibb Co., GlaxoSmithKline plc, Eli Lilly & Co., Merck KGaA, Novo Nordisk A/S, Onyx Pharmaceuticals Inc., Shire plc, and Vertex Pharmaceuticals Inc. Key questions answered in this report: What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Table of Contents
01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Global Biologics Orphan Drugs Market Market Size and Forecast 06.4 Global Non-Biologic Orphan Drugs Market Market Size and Forecast 06.5 Five Forces Analysis 07. Market Segmentation by Product 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 16.1 Competitive Scenario 16.1.1 Key News 16.1.2 Mergers and Acquisitions 16.2 Market Share Analysis 2012 16.3 Other Prominent Vendors 17. Key Vendor Analysis 17.1 Novartis AG 17.1.1 Business Overview 17.1.2 Business Segmentation 17.1.3 Key Information 17.1.4 SWOT Analysis 17.2 F. Hoffmann La Roche Ltd. 17.2.1 Business Overview 17.2.2 Business Segmentation 17.2.3 Key Information 17.2.4 SWOT Analysis 17.3 Celgene Corp. 17.3.1 Business Overview 17.3.2 Key Information 17.3.3 SWOT Analysis 17.4 Pfizer Inc. 17.4.1 Business Overview 17.4.2 Key Information 17.4.3 SWOT Analysis 17.5 Sanofi S.A. 17.5.1 Business Overview 17.5.2 Business Segmentation 17.5.3 Key Information 17.5.4 SWOT Analysis 18. Other Reports in this Series List of Exhibits: Exhibit 1: Market Research Methodology Exhibit 2: Global Orphan Drugs Market 2013-2018 (US$ billion) Exhibit 3: Global Biologics Orphan Drugs Market 2013-2018 (US$ billion) Exhibit 4: Global Non-Biologic Orphan Drugs Market 2013-2018 (US$ billion) Exhibit 5: Global Orphan Drugs Market Segmentation 2013-2018 (by percentage) Exhibit 6: Global Orphan Drugs Market Segmentation by Product Exhibit 7: Global Orphan Drugs Market Segmentation 2013 Exhibit 8: Global Orphan Drugs Market by Geographical Segmentation 2013 Exhibit 9: FDA Approval Time: Orphan vs. Non-Orphan (months) Exhibit 10: Phase Three Trial Length (yrs) Orphan vs. Non-Orphan Exhibit 11: Global Orphan Drugs Market by Vendor Segmentation 2013 Exhibit 12: Global Orphan Drugs Market by Vendor Segmentation 2018 Exhibit 13: Global Orphan Drug Sales: Top 20 companies 2013-2018 Exhibit 14: Global USA and EU Orphan Designations per year (2009-2012) Exhibit 15: Business Segmentation of Novartis AG Exhibit 16: Business Segmentation of F. Hoffmann La Roche Ltd. Exhibit 17: Business Segmentation of Sanofi S.A.
Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commercRead More...October 12, 2015
Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the glRead More...October 13, 2015
Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected toRead More...October 6, 2015
Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the demRead More...October 7, 2015
Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is antRead More...October 30, 2015
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.